Recommended content

AOC’s second bid for psychedelic research amendment rejected, but fellow Democrat gets more love on CBD

Congress has rejected an amendment from Rep. Alexandria Ocasio-Cortez that would have removed legal obstacles to facilitate research into the medicinal potential of psychedelic therapies.

Her fellow Democrat’s amendment fared better, as Rep. Kurt Schrader’s proposed legislation urging the U.S. Food and Drug Administration (FDA) to allow hemp-derived products such like cannabidiol (CBD) to be used in food and dietary supplements got the green light in the House

While speaking on the House floor, Schrader blasted the ambiguity of the current legislation, saying that farmers in his home state of Oregon were facing “economic burdens from the regulatory uncertainty” surrounding CBD.

He later took to Twitter to celebrate the win, calling the results “great news for Oregon farmers!”

Although Ocasio-Cortez’s colleagues in Congress may be tiring of her attempts to pass the amendment, there’s a strong chance they could encounter it

Read full article on The Growth Op

Follow us on Instagram or join us on facebook page

Be first to rate

The Growth Op
Source

More news